Biotech · Public company · Minneapolis, MN, US
DiaMedica Therapeutics Inc.
Ticker DMAC · SEC CIK 0001401040
Track this companyFree. Adds DiaMedica Therapeutics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline3
- Recombinant human tissue kallikreinPhase 3 · Acute StrokeClinicalTrials.gov · fetched Nov 12, 2026
- DM199Phase 2 · Kidney DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- DM199Phase 1 · Chronic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)PHASE2_PHASE3 · RECRUITING · started Nov 7, 2021ClinicalTrials.gov NCT05065216 · fetched Nov 12, 2026
- Multiple Doses of DM199 in Patients With Chronic Kidney Disease (REDUX)PHASE2 · COMPLETED · started Dec 17, 2019ClinicalTrials.gov NCT04123613 · fetched Nov 12, 2026
- Study to Assess PK, Safety and Tolerability in Patients With DM and CKDPHASE1 · COMPLETED · started Feb 12, 2019ClinicalTrials.gov NCT03795389 · fetched Nov 12, 2026
SEC filings12
- 10-Q · FORM 10-QSEC EDGAR · filed Aug 10, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Aug 10, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 21, 2026 · fetched Nov 12, 2026
- 10-Q · FORM 10-QSEC EDGAR · filed May 6, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 6, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Mar 31, 2026 · fetched Nov 12, 2026
- 10-K · FORM 10-KSEC EDGAR · filed Mar 30, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jan 5, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Dec 18, 2025 · fetched Nov 12, 2026
- 10-Q · FORM 10-QSEC EDGAR · filed Nov 12, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Nov 12, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Aug 12, 2025 · fetched Nov 12, 2026